Clinical Trial Update: CGM Use in COVID19 Patients (Infection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) [NA]

View source ↗

Summary

Clinical trial update on continuous glucose monitoring (CGM) use in patients with diabetes mellitus and COVID-19 (SARS-CoV-2). Status: completed; results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Diabetes Mellitus, Covid19 | NA | Status: COMPLETED | Results posted: 2023-08-04